The global GLP-1 Receptor Agonist Market is estimated to be valued at US$ 14319.85 Mn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: GLP-1 receptor agonists are injectable drug products used for the treatment of type 2 diabetes. They work by stimulating the release of...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian